Studies have shown that interleukin-22 is an important factor in the ovarian cancer tumor microenvironment because it stimulates tumor growth by increasing proliferation and serves as a protective factor for ovarian cancer during TNF-induced apoptosis. This evidence concerns the gene TNF and neoplasm.